Karius Test® Improves the Diagnosis and Management of Pneumonia in Patients Undergoing Treatment for Blood Cancer
Karius Inc. Adds Dr. Norman Sharpless, Former National Cancer Institute Head, and Elizabeth O’Farrell, Eli Lilly Veteran, to its Board of Directors
Karius Test®, a Liquid Biopsy for Infectious Diseases, Incorporated into Diagnostics Recommendation in the 2023 Duke-ISCVID Criteria for Infective Endocarditis
The Power of Microbial Cell-Free DNA: Real World Application of a Liquid Biopsy for Endocarditis
Christopher Cooper, MD, Infectious Disease Transplant Specialist
Search through multiple publications showing the efficacy of the Karius Test.
View abstracts that evaluated the metagenomic sequencing of the Karius Test.
View clinical trials validating the Karius Test’s ability to detect pathogens in various clinical contexts.